CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $45,000 | -55.9% | 38,505 | +0.6% | 0.00% | – |
Q2 2022 | $102,000 | +628.6% | 38,268 | +1.2% | 0.00% | – |
Q1 2022 | $14,000 | -84.3% | 37,824 | +30.0% | 0.00% | – |
Q4 2021 | $89,000 | -52.9% | 29,085 | -31.7% | 0.00% | – |
Q3 2021 | $189,000 | -14.5% | 42,570 | +11.6% | 0.00% | – |
Q2 2021 | $221,000 | -7.5% | 38,140 | +12.9% | 0.00% | -100.0% |
Q1 2021 | $239,000 | +81.1% | 33,794 | +22.6% | 0.00% | – |
Q4 2020 | $132,000 | -56.6% | 27,566 | -44.3% | 0.00% | -100.0% |
Q3 2020 | $304,000 | +19.2% | 49,504 | +30.4% | 0.00% | 0.0% |
Q2 2020 | $255,000 | +35.6% | 37,956 | +33.1% | 0.00% | 0.0% |
Q1 2020 | $188,000 | – | 28,515 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |